Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation of citalopram in the STAR*D trial.

Author: BechP, FavaM, RushA J, TrivediM H, WisniewskiS R

Paper Details 
Original Abstract of the Article :
To compare within the framework of a novel pharmacopsychometric triangle, augmentation treatment with bupropion vs. buspirone in the acute therapy of major depression in the STAR*D study. The triangle provides a composite view in three domains of antidepressive activity, side effects, and quality of...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1111/j.1600-0447.2011.01791.x

データ提供:米国国立医学図書館(NLM)

Treating Depression: A Triangular Approach

Major depressive disorder is a complex and debilitating condition that significantly impacts quality of life. This study investigates the effectiveness of two augmentation therapies, bupropion and buspirone, in treating major depression. The researchers used the STAR*D trial, a large-scale clinical trial, to compare the effects of these therapies within the framework of a novel "pharmacopsychometric triangle." This framework considers three domains of antidepressant activity: side effects, quality of life, and antidepressive efficacy. The study found that both bupropion and buspirone were effective in augmenting treatment response in patients with major depression, but they differed in their effects on side effects and quality of life. This study provides valuable insights into the differential effects of augmentation therapies, offering guidance for tailoring treatment strategies to individual patient needs.

Optimizing Depression Treatment: Choosing the Right Path

The study highlights the importance of considering not only the effectiveness of treatment but also its impact on side effects and quality of life. It suggests that different augmentation therapies may be more suitable for certain patients based on their individual needs and preferences.

A Personalized Approach to Depression Treatment

This research underscores the need for a personalized approach to depression treatment. It encourages clinicians to consider the individual patient's needs, including potential side effects and their impact on quality of life, when choosing the most appropriate treatment options.

Dr.Camel's Conclusion

This study is like a map guiding us through the complex landscape of depression treatment, highlighting the importance of considering multiple factors beyond just efficacy. The pharmacopsychometric triangle provides a valuable framework for understanding the multifaceted nature of depression treatment and making informed choices for individual patients.

Date :
  1. Date Completed 2012-06-29
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

22077211

DOI: Digital Object Identifier

10.1111/j.1600-0447.2011.01791.x

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.